NO2504357T3 - - Google Patents

Info

Publication number
NO2504357T3
NO2504357T3 NO10832312A NO10832312A NO2504357T3 NO 2504357 T3 NO2504357 T3 NO 2504357T3 NO 10832312 A NO10832312 A NO 10832312A NO 10832312 A NO10832312 A NO 10832312A NO 2504357 T3 NO2504357 T3 NO 2504357T3
Authority
NO
Norway
Application number
NO10832312A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2504357T3 publication Critical patent/NO2504357T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO10832312A 2009-11-23 2010-11-22 NO2504357T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26360409P 2009-11-23 2009-11-23
PCT/US2010/057592 WO2011063320A2 (en) 2009-11-23 2010-11-22 Recombinant filaggrin polypeptides for cell importation

Publications (1)

Publication Number Publication Date
NO2504357T3 true NO2504357T3 (cg-RX-API-DMAC10.html) 2017-12-30

Family

ID=44060387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10832312A NO2504357T3 (cg-RX-API-DMAC10.html) 2009-11-23 2010-11-22

Country Status (8)

Country Link
US (3) US10336797B2 (cg-RX-API-DMAC10.html)
EP (1) EP2504357B1 (cg-RX-API-DMAC10.html)
AU (1) AU2010321784B2 (cg-RX-API-DMAC10.html)
CA (1) CA2781537C (cg-RX-API-DMAC10.html)
DK (1) DK2504357T3 (cg-RX-API-DMAC10.html)
ES (1) ES2645416T3 (cg-RX-API-DMAC10.html)
NO (1) NO2504357T3 (cg-RX-API-DMAC10.html)
WO (1) WO2011063320A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en) 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
CN106170491B (zh) * 2013-10-30 2020-07-24 阿尔杰妮卡治疗学有限公司 神经保护肽
ES2929579T3 (es) 2014-05-30 2022-11-30 Azitra Inc Tratamiento terapéutico de enfermedades cutáneas con microorganismos cutáneos comensales recombinantes
EP3323827A1 (en) * 2016-11-21 2018-05-23 Christian-Albrechts-Universität zu Kiel Cationic intrinsically disordered antimicrobial peptides
KR102134414B1 (ko) 2017-08-04 2020-07-15 주식회사 케이티 액세스 포인트의 신호 세기를 이용하여 위치를 측정하는 장치 및 방법
EP3678640A4 (en) * 2017-09-05 2021-06-09 Azitra, Inc. METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY SKIN DISEASES WITH RECOMBINANT MICRO-ORGANISMS
KR102958724B1 (ko) 2018-04-05 2026-05-06 아지트라 인코포레이티드 재조합 미생물을 사용하여 피부 질환을 치료하기 위한 방법 및 조성물
EP3856914A1 (en) * 2018-09-26 2021-08-04 Krystal Biotech, Inc. Compositions and methods for the treatment of skin diseases
US11414057B2 (en) * 2019-04-03 2022-08-16 GM Global Technology Operations LLC Retractable pedal assembly for a vehicle
US20230061804A1 (en) * 2020-01-23 2023-03-02 The Rockefeller University Phase separation sensors and uses thereof
CN113045638B (zh) * 2021-04-01 2022-04-15 芜湖英特菲尔生物制品产业研究院有限公司 一种酿酒酵母表达长效重组人丝聚蛋白及其应用
CN118255862B (zh) * 2024-05-30 2024-08-09 湖南中科极美生物科技有限公司 一种重组人源化丝聚蛋白及其制备方法和应用
KR102886023B1 (ko) * 2025-03-19 2025-11-14 주식회사 키프로젠 필라그린 단편 단백질을 이용한 융합 필라그린 단편 단백질 및, 이를 함유하는 화장료 조성물 및 약학 조성물
CN119978096B (zh) * 2025-04-15 2025-07-25 广州市暨源生物科技有限公司 一种具有良好保湿效果的重组人源化丝聚蛋白及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463302A (en) * 1967-09-20 1969-08-26 Pearl M Preston Packaged disposable lotion filled applicator
DE69310339T2 (de) 1993-02-19 1997-08-21 Philippe Djian Präparate, die Corneozyt Proteine enthalten
US6852686B2 (en) 1999-06-23 2005-02-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for ameliorating icthyosiform skin diseases
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
AU1159601A (en) 1999-11-03 2001-05-14 Metris Therapeutics Limited Agents implicated in endometriosis
EP2357478A3 (en) 2000-11-30 2011-11-16 Crawford Healthcare Holdings Limited Diagnosis of disease
DE60233137D1 (de) * 2001-02-16 2009-09-10 Univ R Transporter mit beabstandeten arginin-teilchen
GB0111324D0 (en) 2001-05-09 2001-07-04 Unilever Plc Ambient stable beverage
JP2005509610A (ja) 2001-10-04 2005-04-14 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚の表皮障壁発達の増進
KR100753472B1 (ko) 2002-03-15 2007-08-31 주식회사 엘지생활건강 사람 콜라겐 ⅰ형의 c-말단에서 유래된 펩타이드에tat 펩타이드가 결합된 융합 펩타이드, 이의 제조방법,및 이를 포함하는 피부주름개선 화장료 조성물
IL157786A (en) 2003-09-07 2010-11-30 Ahava Dead Sea Lab Ltd Personalized cosmetics
KR100659138B1 (ko) 2005-09-16 2006-12-19 (주)아모레퍼시픽 유효성분으로 갈로카테킨 갈레이트를 함유하는 보습용피부외용제 조성물
US20090098074A1 (en) * 2005-12-01 2009-04-16 Basf Se Keratin-Binding Effector Molecules Containing Reactive Dyes
GB0525492D0 (en) 2005-12-15 2006-01-25 Univ Dundee Filaggrin
GB0600948D0 (en) 2006-01-18 2006-02-22 Univ Dundee Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
NO2480669T3 (cg-RX-API-DMAC10.html) 2009-09-25 2018-04-07
FR2968303B1 (fr) 2010-12-07 2013-01-18 Oreal Peptides modulateurs du complexe saspase-flg2

Also Published As

Publication number Publication date
US20130018000A1 (en) 2013-01-17
US20190127430A1 (en) 2019-05-02
US20210024600A1 (en) 2021-01-28
DK2504357T3 (en) 2017-10-23
WO2011063320A3 (en) 2011-11-03
US10336797B2 (en) 2019-07-02
EP2504357A4 (en) 2013-09-04
AU2010321784A1 (en) 2012-05-24
CA2781537A1 (en) 2011-05-26
EP2504357A2 (en) 2012-10-03
EP2504357B1 (en) 2017-08-02
WO2011063320A2 (en) 2011-05-26
US11098097B2 (en) 2021-08-24
AU2010321784B2 (en) 2014-04-24
CA2781537C (en) 2022-06-28
ES2645416T3 (es) 2017-12-05

Similar Documents

Publication Publication Date Title
BRPI0925311A2 (cg-RX-API-DMAC10.html)
BR112012008195A2 (cg-RX-API-DMAC10.html)
BRPI0924307A2 (cg-RX-API-DMAC10.html)
BR112012008267A2 (cg-RX-API-DMAC10.html)
BR112012012396A2 (cg-RX-API-DMAC10.html)
BR112012000665A2 (cg-RX-API-DMAC10.html)
BR122021004633A2 (cg-RX-API-DMAC10.html)
BR112012012487A2 (cg-RX-API-DMAC10.html)
BR112012003080A2 (cg-RX-API-DMAC10.html)
BR112012003853A2 (cg-RX-API-DMAC10.html)
BR112012009797A2 (cg-RX-API-DMAC10.html)
BR112012009703A2 (cg-RX-API-DMAC10.html)
BR112012010357A2 (cg-RX-API-DMAC10.html)
BR112012001263A2 (cg-RX-API-DMAC10.html)
BR112012014856A2 (cg-RX-API-DMAC10.html)
BR112012000159A2 (cg-RX-API-DMAC10.html)
BR112012007654A2 (cg-RX-API-DMAC10.html)
BR112012007672A2 (cg-RX-API-DMAC10.html)
BR112012007671A2 (cg-RX-API-DMAC10.html)
BR112012000156A2 (cg-RX-API-DMAC10.html)
BRPI0924617A2 (cg-RX-API-DMAC10.html)
BRPI0925022A2 (cg-RX-API-DMAC10.html)
BR112012016234A2 (cg-RX-API-DMAC10.html)
BRPI0924020A2 (cg-RX-API-DMAC10.html)
BR112012009701A2 (cg-RX-API-DMAC10.html)